Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Brusselle

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
The Lancet. Respiratory Medicine|September 12, 2014
Why doesn't reducing exacerbations decrease COPD mortality?Guy Brusselle
The Lancet. Respiratory Medicine|July 13, 2020
A new once-daily long-acting β<sub>2</sub>-adrenoceptor agonist-inhaled corticosteroid combination therapy for asthmaGuy Brusselle
The Lancet. Respiratory Medicine|April 11, 2014
Should we pursue pulmonary vasodilation in patients with COPD?Guy Brusselle
Rheumatology (Oxford, England)|March 13, 2010
Rheumatoid arthritis and interstitial lung diseaseGuy Brusselle
Thorax|August 9, 2014
Dysregulated fibulin-5 expression and elastogenesis in COPD lungs: pyromaniac or fire fighter?Guy Brusselle
Lancet (London, England)|May 21, 2016
Vilanterol fluticasone and mortality in comorbid COPD GOLD BGuy Brusselle
Annals of the American Thoracic Society|December 20, 2014
Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary diseaseGuy Brusselle, Ken Bracke
Lancet (London, England)|July 9, 2017
Azithromycin in uncontrolled asthmaGuy Brusselle, Ian Pavord
American Journal of Respiratory and Critical Care Medicine|June 6, 2023
Reply to Lipworth and ChanGuy Brusselle, Sebastian Riemann
Expert Opinion on Medical Diagnostics|October 9, 2013
Challenges of COPD diagnosisDavid Price, Guy Brusselle
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
The Lancet. Respiratory Medicine|September 12, 2014
Why doesn't reducing exacerbations decrease COPD mortality?Guy Brusselle
The Lancet. Respiratory Medicine|July 13, 2020
A new once-daily long-acting β<sub>2</sub>-adrenoceptor agonist-inhaled corticosteroid combination therapy for asthmaGuy Brusselle
The Lancet. Respiratory Medicine|April 11, 2014
Should we pursue pulmonary vasodilation in patients with COPD?Guy Brusselle
Rheumatology (Oxford, England)|March 13, 2010
Rheumatoid arthritis and interstitial lung diseaseGuy Brusselle
Thorax|August 9, 2014
Dysregulated fibulin-5 expression and elastogenesis in COPD lungs: pyromaniac or fire fighter?Guy Brusselle
Lancet (London, England)|May 21, 2016
Vilanterol fluticasone and mortality in comorbid COPD GOLD BGuy Brusselle
Annals of the American Thoracic Society|December 20, 2014
Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary diseaseGuy Brusselle, Ken Bracke
Lancet (London, England)|July 9, 2017
Azithromycin in uncontrolled asthmaGuy Brusselle, Ian Pavord
American Journal of Respiratory and Critical Care Medicine|June 6, 2023
Reply to Lipworth and ChanGuy Brusselle, Sebastian Riemann
Expert Opinion on Medical Diagnostics|October 9, 2013
Challenges of COPD diagnosisDavid Price, Guy Brusselle
Pageof 21